Science & Technology
2-HOBA for Treatment of Pulmonary Hypertension
Department of Health and Human Services — National Institutes of Health
Opportunity #: 2R42HL158393-02
Award Ceiling
$3.1M
Award Floor
$3.1M
Close Date
Aug 31, 2026
169 days leftTotal Funding
$3.1M
Expected Awards
1
Posted Date
Sep 1, 2023
Cost Sharing Required
No
Grants.gov ID
sbir-2R42HL158393-02
Description
STTR Phase Phase II award: "2-HOBA for Treatment of Pulmonary Hypertension" awarded to MTI Biotech Incorporated in Ames, Iowa. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $3,088,886. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.